Issues in the economic evaluation of influenza vaccination by injection of healthy working adults in the US: A review and decision analysis of ten published studies

PharmacoEconomics

Volumn 30, Issue 5, 2012, Pages 355-371

  Hogan, Thomas J ^a  

^a NONE   (United States)

Author keywords

Adults; Cost effectiveness; Decision analysis; Healthcare expenditure; Influenza virus infections; Influenza virus vaccine

Indexed keywords

INFLUENZA VACCINE; OSELTAMIVIR; PLACEBO; RIMANTADINE; ZANAMIVIR;

ANTIVIRAL THERAPY; COST EFFECTIVENESS ANALYSIS; DRUG COST; DRUG EFFICACY; HEALTH CARE COST; HUMAN; INFLUENZA; INFLUENZA VACCINATION; MEDICAL DECISION MAKING; MEDICAL LEAVE; PRIORITY JOURNAL; QUALITY OF LIFE; REVIEW; SEASONAL INFLUENZA;

EID: 84859792383     PISSN: 11707690     EISSN: 11792027     Source Type: Journal    
DOI: 10.2165/11596890-000000000-00000     Document Type: Review

References (24)

1. Centers for Disease Control and Prevention. Seasonal influenza (flu): questions and answers [online]. Available from URL: http://www.cdc.gov/flu/ about/qa/disease.htm [Accessed 2011 May 12]
2. Bush RM. Influenza evolution. In: Tibayrenc M, editor. Encyclopedic guide to infectious disease research: modern methodologies. Hoboken (NJ): John Wiley and Sons, 2007: 199-214
3. Centers for Disease Control and Prevention. Seasonal influenza (flu): key facts [online]. Available from URL: http:// www.cdc.gov/flu/keyfacts.htm. [Accessed 2010 Apr 5]
4. Rothberg MB, Rose DN. Vaccination versus treatment of influenza in working adults: a cost-effectiveness analysis. Am J Med 2005; 118: 68-77
5. LeMaire J. 2010 Flu vaccine: new CDC recommendations, H1N1 protection, earlier availability [online].Available from URL: http://www.associatedcontent. com/article/5641302/ 2010-flu-vaccine-new-cdc-recommendations.html?cat=5 [Accessed 2010 Nov 3]
6. Brent RJ. Cost-benefit analysis and health care evaluations. Northampton (MA): Edward Elgar Publishing Inc, 2003
7. Drummond MF, Sculpher M, Torrance GW. Methods for the economic evaluation of health care programmes. Oxford: Oxford University Press, 2005
8. Warner KE, Luce BR. Cost-benefit and cost-effectiveness analysis in health care. Ann Arbor (MI): Health Administration Press, 1982
9. Gold MR, Siegel JG, Russell LB, et al. Cost-effectiveness in health and medicine. Oxford: Oxford University Press, 1996
10. Nichol KL, Lind A, Margolis KL, et al. The effectiveness of vaccination against influenza in healthy, working adults. New Engl J Med 1995; 333: 889-93
11. Campbell DS, Rumley MH. Cost-effectiveness of the influenza vaccine in a healthy, working-age population. J Occup Environ Med 1997; 39-45
12. Bridges CA, Thompson WW, Meltzer MI, et al. Effectiveness and cost-benefit of influenza vaccination of healthy working adults: a randomized controlled trial. JAMA 2000; 284 (13): 1655-63
13. Nichol KL. Cost-benefit analysis of a strategy to vaccinate healthy working adults against influenza. Arch Intern Med 2001; 161 (5): 749-59
14. Muennig PA, Khan K. Cost-effectiveness of vaccination versus treatment of influenza in healthy adolescents and adults. Clin Infect Dis 2001; 33 (11): 1879-85
15. Lee PY, Matchar DB, Clements DA, et al. Economic analysis of influenza vaccination and antiviral treatment for healthy adults. Ann Int Med 2002; 137 (4): 225-31
16. Maciosek MV, Solberg LI, Coffield AB, et al. Influenza vaccination, health impact and cost effectiveness among adults aged 50 to 64 and 65 and older. Am J PrevMed 2006; 31 (1): 72-9
17. Hogan TJ, Doyle JJ, Mauceri E. An economic model of the expected impact of an employer-sponsored influenza vaccination program for employees and their household members. J Health Product 2008; 3 (2): 3-9
18. US Bureau of Labor Statistics. Consumer price index [online]. Available fromURL: http://www.bls.gov/cpi/home. htm [Accessed 2010 Nov 5]
19. Motulsky H. Intuitive biostatistics. New York (NY): Oxford University Press, 1995
20. TreeAge Software. DATA 3.0: user's manual. Williamstown (MA): TreeAge Software, Inc., 1997
21. Kahneman D. Thinking, fast and slow. New York: Farrar, Straus and Giroux, 2011
22. Wood SC, Nguyen VH, Schmidt C. Economic evaluations of influenza vaccination in healthy working-age adults: employer and society perspective. Pharmacoeconomics 2000; 18 (2): 173-83
23. Newall AT, Kelly H, Harsley S, et al. Cost effectiveness of influenza vaccination in older adults: a critical review of economic evaluations for the 50- and 64-year age group. Pharmacoeconomics 2009; 27 (6): 439-50
24. Prosser LA, O'BrienMA,MolinariNA, et al. Non-traditional settings for influenza vaccination of adults: costs and cost effectiveness. Pharmacoeconomics 2008; 26 (2): 163-78